Neutra Life Sciences Forms Women's Health JV, Secures New Clinical Trials
Summary
Neutra Corp's subsidiary, Neutra Life Sciences, announced a new joint venture with Women's Healthcare Center of Baytown, expanding its clinical research site network into women's health. The subsidiary also secured new clinical trials in Oncology, Dermatology, Pulmonology, and Women's Health, along with new sponsor contracts. For a micro-cap company, this expansion of partnerships and trial portfolio represents significant business development and potential for future revenue growth. The company anticipates continued growth and additional trial opportunities through the second half of 2026.
At the time of this announcement, NTRR was trading at $0.00 on OTC in the Life Sciences sector, with a market capitalization of approximately $583.6K. The 52-week trading range was $0.00 to $0.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.